CIK 0001274737 · Non-accelerated filer<br>Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (760) 560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- Open-market buys, last 90 days
- $568,660
- in 3 filings
- Open-market sales, last 90 days
- $487,740
- in 3 filings
Net +$80,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 39 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-14 | ABALLI JOHN President and CEO | Purchase | +24,305 | $2.81 | $68K | 689,799 |
| 2024-09-01 | Black Jeffrey G. Chief Financial Officer | Grant or award | +225,000 | 252,194 | ||
| 2024-06-10 | KAHN SCOTT D Director | Grant or award · Stock Option(right to buy) | +15,000 | 15,000 | ||
| 2024-06-10 | Stokes Frank Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2024-06-10 | Hooker Ana Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2024-06-10 | Kim Paul Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 | ||
| 2024-06-10 | Nova Tina Susan Director | Grant or award · Stock Option(right to buy) | +13,500 | 13,500 | ||
| 2024-05-16 | ABALLI JOHN President and CEO | Purchase | +40,401 | $1.92 | $78K | 40,401 |
| 2024-03-04 | Adawi Kamal CFO and Corporate Secretary | Sale | −9,297 | $1.91 | $18K | 247,236 |
| 2024-03-04 | Adawi Kamal CFO and Corporate Secretary | Sale | −3,487 | $1.91 | $7K | 243,749 |
| 2024-02-29 | ABALLI JOHN President and CEO | Grant or award | +9,804 | $1.91 | $19K | 600,788 |
| 2024-02-20 | Adawi Kamal CFO and Corporate Secretary | Grant or award | +75,000 | 256,533 | ||
| 2024-02-20 | ABALLI JOHN President and CEO | Grant or award | +175,000 | 590,984 | ||
| 2024-02-06 | Adawi Kamal CFO and Corporate Secretary | Sale | −6,738 | $1.95 | $13K | 181,533 |
| 2023-10-17 | ABALLI JOHN President and CEO | Sale | −33,819 | $1.75 | $59K | 415,984 |
| 2023-08-31 | ABALLI JOHN President and CEO | Grant or award | +9,803 | $2.14 | $21K | 449,803 |
| 2023-07-24 | Kim Paul Director | Grant or award · Stock Option(right to buy) | +15,000 | 15,000 | ||
| 2023-06-15 | Nova Tina Susan Executive Chairperson | Grant or award · Stock Option(right to buy) | +13,500 | 13,500 | ||
| 2023-06-15 | TULLIS JAMES L L 10% owner | Purchase | +167 | $3.11 | $519 | 1,515,839 |
| 2023-06-09 | Stokes Frank Director | Grant or award · Stock Option(right to buy) | +9,000 | 9,000 |
Page 3 of 7 · 126 trades